RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Approx 3.5 million warrants expiring on August 14, 2024And what this biopharmdive article reveals seems to be where ONCY is at in the following comment:
"Companies with more proven drug assets are prized commodities."